South Korea
# |
Name |
Current Liabilities |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
USD 3.19 B
|
Dec. 31, 2023 | USD 745.69 | 1.15% |
|
South Korea |
|
2 |
USD 1.90 B
|
Dec. 31, 2023 | USD 119.86 | -2.20% |
|
South Korea |
|
3 |
USD 1.16 B
|
Dec. 31, 2023 | USD 9.61 | -3.70% |
|
South Korea |
|
4 |
USD 687.81 M
|
Dec. 31, 2023 | USD 5.23 | -2.06% |
|
South Korea |
|
5 |
USD 667.33 M
|
Dec. 31, 2023 | USD 88.80 | -5.65% |
|
South Korea |
|
6 |
USD 541.26 M
|
Dec. 31, 2023 | USD 159.35 | -4.24% |
|
South Korea |
|
7 |
USD 530.69 M
|
Dec. 31, 2023 | USD 13.69 | -2.57% |
|
South Korea |
|
8 |
USD 483.02 M
|
Dec. 31, 2023 | USD 65.38 | -0.04% |
|
South Korea |
|
9 |
USD 481.02 M
|
Dec. 31, 2023 | USD 89.76 | -4.42% |
|
South Korea |
|
10 |
USD 399.29 M
|
Dec. 31, 2023 | USD 31.05 | -1.12% |
|
South Korea |
|
11 |
USD 392.81 M
|
Dec. 31, 2023 | USD 56.39 | -4.53% |
|
South Korea |
|
12 |
USD 350.83 M
|
Dec. 31, 2023 | USD 3.69 | -1.06% |
|
South Korea |
|
13 |
USD 303.52 M
|
Dec. 31, 2023 | USD 18.22 | -3.57% |
|
South Korea |
|
14 |
USD 300.64 M
|
Dec. 31, 2023 | USD 33.57 | -2.13% |
|
South Korea |
|
15 |
USD 276.38 M
|
Dec. 31, 2023 | USD 83.97 | -5.00% |
|
South Korea |
|
16 |
USD 246.34 M
|
Dec. 31, 2023 | USD 8.02 | 4.65% |
|
South Korea |
|
17 |
USD 231.53 M
|
Dec. 31, 2023 | USD 7.87 | -2.10% |
|
South Korea |
|
18 |
USD 231.28 M
|
Dec. 31, 2023 | USD 23.36 | -2.28% |
|
South Korea |
|
19 |
USD 220.36 M
|
Dec. 31, 2023 | USD 15.49 | -2.92% |
|
South Korea |
|
20 |
USD 191.50 M
|
Dec. 31, 2023 | USD 34.59 | -4.65% |
|
South Korea |
|
21 |
USD 185.56 M
|
Dec. 31, 2023 | USD 70.28 | -5.55% |
|
South Korea |
|
22 |
USD 177.53 M
|
Dec. 31, 2023 | USD 9.85 | -4.50% |
|
South Korea |
|
23 |
USD 154.43 M
|
Dec. 31, 2023 | USD 6.82 | -1.91% |
|
South Korea |
|
24 |
USD 140.31 M
|
Dec. 31, 2023 | USD 9.80 | -1.72% |
|
South Korea |
|
25 |
USD 133.51 M
|
Dec. 31, 2023 | USD 7.33 | -4.07% |
|
South Korea |
|
26 |
USD 129.54 M
|
Dec. 31, 2023 | USD 8.58 | -5.12% |
|
South Korea |
|
27 |
USD 126.43 M
|
Dec. 31, 2023 | USD 11.86 | -0.20% |
|
South Korea |
|
28 |
USD 124.53 M
|
Dec. 31, 2023 | USD 15.77 | -2.26% |
|
South Korea |
|
29 |
USD 121.30 M
|
Dec. 31, 2023 | USD 0.50 | -4.09% |
|
South Korea |
|
30 |
USD 111.01 M
|
Dec. 31, 2023 | USD 11.62 | -0.90% |
|
South Korea |
|
31 |
USD 104.16 M
|
Dec. 31, 2023 | USD 32.21 | -3.61% |
|
South Korea |
|
32 |
USD 104.03 M
|
Dec. 31, 2023 | USD 7.21 | -0.62% |
|
South Korea |
|
33 |
USD 97.20 M
|
Dec. 31, 2023 | USD 77.77 | -3.69% |
|
South Korea |
|
34 |
USD 96.46 M
|
Dec. 31, 2023 | USD 8.44 | -2.89% |
|
South Korea |
|
35 |
USD 89.37 M
|
Dec. 31, 2023 | USD 1.12 | -3.94% |
|
South Korea |
|
36 |
USD 87.91 M
|
Dec. 31, 2023 | USD 12.66 | -2.66% |
|
South Korea |
|
37 |
USD 81.51 M
|
Dec. 31, 2023 | USD 4.07 | -1.95% |
|
South Korea |
|
38 |
USD 78.21 M
|
Dec. 31, 2023 | USD 15.36 | -2.10% |
|
South Korea |
|
39 |
USD 77.12 M
|
Dec. 31, 2023 | USD 240.05 | -5.25% |
|
South Korea |
|
40 |
USD 77.01 M
|
Dec. 31, 2023 | USD 4.14 | -7.03% |
|
South Korea |
|
41 |
USD 75.74 M
|
Dec. 31, 2023 | USD 14.37 | -3.79% |
|
South Korea |
|
42 |
USD 74.91 M
|
Dec. 31, 2023 | USD 3.10 | -3.13% |
|
South Korea |
|
43 |
USD 70.85 M
|
Dec. 31, 2023 | USD 3.22 | 0.07% |
|
South Korea |
|
44 |
USD 64.32 M
|
Dec. 31, 2023 | USD 54.68 | -7.62% |
|
South Korea |
|
45 |
USD 58.66 M
|
Dec. 31, 2023 | USD 6.88 | -1.99% |
|
South Korea |
|
46 |
USD 57.64 M
|
Dec. 31, 2023 | USD 1.37 | -0.64% |
|
South Korea |
|
47 |
USD 54.99 M
|
Dec. 31, 2023 | USD 1.73 | -2.46% |
|
South Korea |
|
48 |
USD 48.52 M
|
Dec. 31, 2023 | USD 2.87 | -2.35% |
|
South Korea |
|
49 |
USD 45.85 M
|
Dec. 31, 2023 | USD 3.25 | -3.09% |
|
South Korea |
|
50 |
USD 42.66 M
|
Dec. 31, 2023 | USD 1.61 | -1.19% |
|
South Korea |
The Healthcare company in South Korea with the highest Current Liabilities is Samsung Biologics Co.,Ltd. (KSE: 207940.KS) at USD 3.19 B.
The Healthcare company in South Korea with the lowest Current Liabilities is iNtRON Biotechnology, Inc. (KOSDAQ: 048530.KQ) at USD 603.62 K.
The top 10 Healthcare companies in South Korea by Current Liabilities are Samsung Biologics Co.,Ltd., Celltrion, Inc., Green Cross Holdings Corporation, iMarketKorea Inc., Green Cross Corporation, Hanmi Pharm. Co., Ltd., Daewoong Co., Ltd., Dong-A Socio Holdings Co., Ltd., Daewoong pharmaceutical Co.,Ltd and Chong Kun Dang Holdings Corp..
The bottom 10 Healthcare companies in South Korea by Current Liabilities are iNtRON Biotechnology, Inc., OliX Pharmaceuticals,Inc, Peptron, Inc., Hyundai Bioscience Co., Ltd., EOFLOW Co.,Ltd., MedPacto, Inc., Pharmicell Co., Ltd., RSUPPORT Co., Ltd., SillaJen, Inc. and Cellid, Co., Ltd..